Raymond J. Henley Iii

Array ( [id] => 6408605 [patent_doc_number] => 20020037903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Use of pyrimidine endothelin antagonists in companion animals' [patent_app_type] => new [patent_app_number] => 09/779413 [patent_app_country] => US [patent_app_date] => 2001-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6577 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037903.pdf [firstpage_image] =>[orig_patent_app_number] => 09779413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6640489 [patent_doc_number] => 20030212114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Stable emulsion compositions' [patent_app_type] => new [patent_app_number] => 10/182762 [patent_app_country] => US [patent_app_date] => 2002-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 30770 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212114.pdf [firstpage_image] =>[orig_patent_app_number] => 10182762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6891891 [patent_doc_number] => 20010018053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-30 [patent_title] => 'Methods for treating disease states comprising administration of low levels of antibodies' [patent_app_type] => new [patent_app_number] => 09/774770 [patent_app_country] => US [patent_app_date] => 2001-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2282 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20010018053.pdf [firstpage_image] =>[orig_patent_app_number] => 09774770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7093771 [patent_doc_number] => 20010034335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-25 [patent_title] => 'Apoptosis inducers' [patent_app_type] => new [patent_app_number] => 09/770504 [patent_app_country] => US [patent_app_date] => 2001-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 38720 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20010034335.pdf [firstpage_image] =>[orig_patent_app_number] => 09770504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495423 [patent_doc_number] => 06403571 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-06-11 [patent_title] => 'Combination therapy for reducing the risks associated with cardiovascular disease' [patent_app_type] => B2 [patent_app_number] => 09/764511 [patent_app_country] => US [patent_app_date] => 2001-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7851 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403571.pdf [firstpage_image] =>[orig_patent_app_number] => 09764511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410303 [patent_doc_number] => 06310094 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Ready-to-use esmolol solution' [patent_app_type] => 1 [patent_app_number] => 9/759547 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1747 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310094.pdf [firstpage_image] =>[orig_patent_app_number] => 759547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494713 [patent_doc_number] => 06342526 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Method for enhancing or achieving training-induced bradycardia with Carnitine' [patent_app_type] => B1 [patent_app_number] => 09/760390 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3413 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342526.pdf [firstpage_image] =>[orig_patent_app_number] => 09760390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440277 [patent_doc_number] => 06495538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-17 [patent_title] => 'Zinc ionophores as therapeutic agents' [patent_app_type] => B2 [patent_app_number] => 09/759091 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 28 [patent_no_of_words] => 16771 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495538.pdf [firstpage_image] =>[orig_patent_app_number] => 09759091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6515429 [patent_doc_number] => 20020026063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Process for making an enriched mixture of polyunsaturated fatty acid esters' [patent_app_type] => new [patent_app_number] => 09/758973 [patent_app_country] => US [patent_app_date] => 2001-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7006 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20020026063.pdf [firstpage_image] =>[orig_patent_app_number] => 09758973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1486917 [patent_doc_number] => 06428817 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Companion animal therapeutic treat' [patent_app_type] => B1 [patent_app_number] => 09/743449 [patent_app_country] => US [patent_app_date] => 2001-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2132 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428817.pdf [firstpage_image] =>[orig_patent_app_number] => 09743449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6882912 [patent_doc_number] => 20010049384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-06 [patent_title] => 'Method of treatment and pharmaceutical composition' [patent_app_type] => new [patent_app_number] => 09/757413 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2800 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20010049384.pdf [firstpage_image] =>[orig_patent_app_number] => 09757413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7040974 [patent_doc_number] => 20010005579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-06-28 [patent_title] => 'Method and compositions for increasing the anaerobic working capacity in tissues' [patent_app_type] => new-utility [patent_app_number] => 09/757782 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7200 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20010005579.pdf [firstpage_image] =>[orig_patent_app_number] => 09757782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1459951 [patent_doc_number] => 06391867 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-05-21 [patent_title] => 'Use of spironolactone for treatment of symptomatic heart failure' [patent_app_type] => B2 [patent_app_number] => 09/756892 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5920 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391867.pdf [firstpage_image] =>[orig_patent_app_number] => 09756892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4361068 [patent_doc_number] => 06255355 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'Method of inhibiting angiogenesis' [patent_app_type] => 1 [patent_app_number] => 9/756033 [patent_app_country] => US [patent_app_date] => 2001-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1755 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255355.pdf [firstpage_image] =>[orig_patent_app_number] => 756033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92195 [patent_doc_number] => 07737108 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-06-15 [patent_title] => 'Enhanced transport using membrane disruptive agents' [patent_app_type] => utility [patent_app_number] => 09/755701 [patent_app_country] => US [patent_app_date] => 2001-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 12544 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/737/07737108.pdf [firstpage_image] =>[orig_patent_app_number] => 09755701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6892251 [patent_doc_number] => 20010018413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-30 [patent_title] => 'Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists' [patent_app_type] => new [patent_app_number] => 09/754840 [patent_app_country] => US [patent_app_date] => 2001-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5243 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20010018413.pdf [firstpage_image] =>[orig_patent_app_number] => 09754840 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1173327 [patent_doc_number] => 06750208 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-15 [patent_title] => 'Medicine for treating apoptosis dysfunction containing oligosaccharides' [patent_app_type] => B1 [patent_app_number] => 09/601665 [patent_app_country] => US [patent_app_date] => 2000-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 7267 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750208.pdf [firstpage_image] =>[orig_patent_app_number] => 09601665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1545729 [patent_doc_number] => 06444649 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Solid dispersion containing sialic acid derivative' [patent_app_type] => B1 [patent_app_number] => 09/646873 [patent_app_country] => US [patent_app_date] => 2000-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5859 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444649.pdf [firstpage_image] =>[orig_patent_app_number] => 09646873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1501080 [patent_doc_number] => 06486188 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'Method of treatment for cardiovascular complications' [patent_app_type] => B1 [patent_app_number] => 09/720289 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2241 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/486/06486188.pdf [firstpage_image] =>[orig_patent_app_number] => 09720289 [rel_patent_id] =>[rel_patent_doc_number] =>)